Association between disease-modifying therapies and adverse clinical outcomes in multiple sclerosis patients with COVID-19 infection.

Background: This study aimed to consider the main risk factors related to adverse clinical outcomes in MS patients with COVID-19.

Methods: Using the electronic health records systems, this is a cross-sectional study of two years of hospital admissions in terms of COVID-19 in Iran from March 2019 to August 2021. The severities of COVID-19 outcomes were admitted to ICU, hospitalization days, and in-hospital mortality.

Bone mineral density and muscle mass in adults with developmental skeletal discrepancies.

Background: It was aimed to investigate the musculoskeletal status in individuals diagnosed with skeletal discrepancies.

Methods: This case-control study was performed on 35 patients with developmental skeletal discrepancies listed for orthognathic surgery as a case group and 33 patients who were nominated for wisdom tooth removal as a control group. All participants were aged 18-40 years and the research was carried out in the period between May 2018 and May 2019.